For many years the DGSP (German Society for Social Psychiatry) has been intensively engaged in the issue of the use of neuroleptics when it comes to the treatment of mentally ill people. The use of neuroleptics has been widely discussed at several regional and federal interdisciplinary DGSP meetings and events with the participation of users/consumers/survivors and their family members.
This memorandum is the result and the future development of this intensive debate in Germany. It wants to encourage further discourse in our country regarding psychopharmacological therapy, which is a very important question for mentally ill people.
The memorandum shows our critical position and offers much information for family members, users/consumers/survivors and professionals.